Molecule to Market: Inside the outsourcing space

← Molecule to Market: Inside the outsourcing space16 okt · 52 min

CPHI Milan Live: What matters more now?

CPHI Milan Live: What matters more now?16 okt52 min

Live from CPHI Milan, Molecule to Market and ramarketing bring together 11 senior leaders from across the global pharma outsourcing sector to tackle some of the industry's biggest trade-offs.

In this special episode, produced in partnership with ramarketing, host Raman Sehgal cuts through the usual industry talking points with a series of rapid-fire, either-or questions designed to uncover what leaders are really prioritizing, where opinions align, and where perspectives differ.

From balancing cost with flexibility to weighing technology against human expertise, we explore the decisions shaping the future of pharma services, what customers value most, and where the industry could be heading over the next five years.

Expect different perspectives, some tough choices, and plenty of food for thought from the people helping shape the future of pharma outsourcing.

Featuring insights from:

Maja Pedersen, President and COO at Fujifilm Biotechnologies

Hayley Crowe, Executive VP and General Manager of Global Life Sciences at Ecolab

John Wichelt, VP/General Manager at Kindeva

Henning Steinhagen, CEO at Symeres

Campbell Bunce, Chief Scientific Officer at Abzena

Patrick Kelley, Senior Director - Commercial at Pace Life Sciences

Matt Peterson, Chief Strategy Officer at Quotient Sciences